506690 logo

Unichem Laboratories Limited Stock Price

BSE:506690 Community·₹33.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

506690 Share Price Performance

₹479.65
-380.90 (-44.26%)
₹479.65
-380.90 (-44.26%)
Price ₹479.65

506690 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with questionable track record.

1 Risk
1 Reward

Unichem Laboratories Limited Key Details

₹22.3b

Revenue

₹10.3b

Cost of Revenue

₹12.0b

Gross Profit

₹11.1b

Other Expenses

₹884.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
12.56
53.74%
3.97%
19.4%
View Full Analysis

About 506690

Founded
1944
Employees
3142
CEO
Pabitra Kumar Bhattacharyya
WebsiteView website
www.unichemlabs.com

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.

Recent 506690 News & Updates

Recent updates

No updates